International Journal of Oral Biology

The Korean Academy of Oral Biology (대한구강생물학회)
권호 표지

Anti-proliferative and Apoptosis Inducing Effect of Resveratrol on Human Osteogenic Sarcoma (HOS) Cells

  • Han, Dong-Hoon (Dept. of Biochemistry, College of Dentistry, Institute of Oral Biology, KyungHee University) ;
  • Kwon, Hee-Young (Dept. of Biochemistry, College of Dentistry, Institute of Oral Biology, KyungHee University) ;
  • Kim, Jeong-Hee (Dept. of Biochemistry, College of Dentistry, Institute of Oral Biology, KyungHee University)
  • Published : 2005.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Resveratrol (3,4',5-trihydroxy-trans-stilbene), a naturally occuring polyphenol compound which present in the skin of grapes and red wine has been considered to posses chemopreventive and antioxidant properties. However, little is known about the cellular actions by which resveratrol mediates its therapeutic effects. In this study, the effect of resveratrol on cell proliferation and induction of apoptosis in human osteogenic sarcoma (HOS) cells was investigated. $IC_{50}$ value was determined to be approximately $6.0{\mu}g/ml$. Chromosomal DNA framgmentation analysis showed the appearance degraded DNA in time-and dose-dependent manner upon treatment of resveratrol. In order to observe the molecular mechanism involved in resveratrol-induced apoptosis, Western blot analysis was performed. We observed the decrease in the level of procaspase-3, the zymogen form of active caspase-3 in resveratrol-treated cells. This result implies that caspase-3 is activated upon treatment of resveratrol. The activation of caspase-3 was confirmed by the cleavage of poly(ADP-ribose) polymerase. Taken together, our data demonstrate that resveratrol has anti-proliferative effect on HOS cells and induced apoptosis through activation of caspase-3 and PARP cleavage.

Keywords

References

  1. Azmi, A.S., Bhat, S.H., and Hadi, S.M.: Resveratrol-Cu(II) induced DNA breakage in human peropheral lymphocytes: Implication for anticancer properties. FEBS Lett., 579:3131-3135, 2005 https://doi.org/10.1016/j.febslet.2005.04.077
  2. Bomser, J., Madhavi, D.L., Singletary, K., and Smith, M.A.L.: In vitro anticancer activity of fruit extracts from Vaccinium species. Planta Medica, 62: 212-216, 1996 https://doi.org/10.1055/s-2006-957862
  3. Chanvitayapongs, S., Oraczynska-Lusiak, B., and Sun, A.Y.: Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells. Neuroreport. 8:1499-1502, 1997 https://doi.org/10.1097/00001756-199704140-00035
  4. Dong, Z.: Molecular mechanism of the chemopreventive effect of resveratrol. Mut. Res. 523:145-150, 2003 https://doi.org/10.1016/S0027-5107(02)00330-5
  5. Gonzales, D.H., and Neupert, W.: Biogenesis of mitochondrial c-type cytochromes. J. Bioenerg. Biomembr. 22:753-768, 1990
  6. Hockenbery, D.M., Oltvai, Z.N., Yin, X.M., Milliman, C.L., and Korsmeyer, S.J.: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell, 75: 241-251, 1993 https://doi.org/10.1016/0092-8674(93)80066-N
  7. Howard, S.P., Park, SJ., Hghes-Davies, L., Coleman, C.N., and Price, B.D.: Suramin increases p53 protein levels but does not activate the p53-dependent G1 checkpoint. Clin. Cancer Res. 2:269-276, 1996
  8. Hyun, S.J., Yoon, M.Y., Kim, T.H., and Kim, J.H.: Enhancement of mitogen-stimulated proliferation of low dose radiation-adapted mouse splenocytes. Anticancer Res. 17:225-230, 1997
  9. Jang, J.H., and Surh, Y.J.: Protective effect of resveratrol on beta-amyloid -induced oxidative PC12 cell death. Free. Radic. Biol. Med. 34:1100-1110, 2003 https://doi.org/10.1016/S0891-5849(03)00062-5
  10. Jang, J.H., and Surh, Y.J.: Protective effects of resveratrol on hydrogenperoxide -induced apoptosis in rat pheochromocytoma (PCI2) cells. Mutat. Res. 496:181-190, 2001 https://doi.org/10.1016/S1383-5718(01)00233-9
  11. Jang, M., Cai, L., Udeani, G.O., and Pezzuto, J.M.: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 275:218-220, 1997 https://doi.org/10.1126/science.275.5297.218
  12. Jiang, H., Zhang, L., Kuo, K., Gautam, S.C., Groc, L., Rodriguez, A.I., Koubi, D., Hunter, T.J., Corcoran, G.B., Seidman M.D., Levine, R.A.: Resveratrol-induced apoptotic death in human U251 glioma cells. Mol. Cancer Res. 4:554-561, 2005
  13. Ju, E.M., Lee, S.E., Hwang H.J., and Kim, J.H.: Antioxidant and anticancer activity of extract from Betula platyphylla var. japonica. Life Sci. 74: 1013-1026, 2004 https://doi.org/10.1016/j.lfs.2003.07.025
  14. Kang J.H., Park, Y.H., Choi, S.W., Yang E.K., and Lee W.J.: Resveratrol derivatives potentially induce apoptosis in human promyelocytic leukemia cells. Exp. Mol. Med. 35:467-474, 2003 https://doi.org/10.1038/emm.2003.61
  15. Kerr J.F., Winterford C.M., and Harmon, B.V.: Apoptosis: its significance in cancerand cancer therapy. Cancer, 73:2013-2026, 1994 https://doi.org/10.1002/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO;2-J
  16. Kim, J.H., Ju, E.M., Lee, D.G., and Hwang, H.J.: Induction of apoptosis by momordin I in promyelocytic leukemia (HL-60) cells. Anticancer Res, 22: 1885-1890, 2002
  17. Koki, A.T., and Masferrer, J.L.: Celecoxib: A specific COX-2 inhibitor with anticancer properties. Cancer Control, 9:28-35, 2002
  18. Lee, E. and Surh, Y.J.: Induction of apoptosis in HL-60 cells by pungent vanilloid,6-gingerol and 6-parpadol. Caner Lett. 134:163-168, 1998 https://doi.org/10.1016/S0304-3835(98)00253-5
  19. Lee, S.J., Lo, W.K., Kim, J.H., Sung, J.H., Lee, J.H., Moon, C.K., Lee, B,H.: Induction of apoptosis by a novel intestinal metabolite of ginseng saponin via cytochrome c-mediated activation of caspase-3 protease. Biochem. Phamacol. 60:677-685, 2000 https://doi.org/10.1016/S0006-2952(00)00362-2
  20. Lowry, O.H., Rosenberg, N.J., Farr, A.L. and Randall, R.J..: Protein measurement with the folin phenol reagent. J. Biok. Chem. 193:265-275, 1951
  21. Lu, J., Kunitomo, S., Yamazaki, Y., Kaminish, M. and Esumi, H.: Kigamicin, a novel anticancer agent based on a new antiausterity strategy targeting cancer cells' tolerance to nutrient starvation. Cancer Sci. 95:547-552, 2004 https://doi.org/10.1111/j.1349-7006.2004.tb03247.x
  22. Lui, X., Kim, C.N., Yang, J., Jemmerson, R., and Wang, X.: Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell, 86:147-157, 1996 https://doi.org/10.1016/S0092-8674(00)80085-9
  23. Malet-Martino, M., and Martino, R : Clinical studies of three prodrugs of 5-fluorouracil (Capecitabine, UFT, S-1): A review. The Oncologist, 7: 288-323, 2002 https://doi.org/10.1634/theoncologist.7-4-288
  24. Marttila, R.J., Lorenz H., and Rinne, U.K.: Oxygen toxicity protecting enzymes in Parkinson's disease. J. Neurol. Sci. 86:321-325, 1988 https://doi.org/10.1016/0022-510X(88)90108-6
  25. Mastrangelo A.J., and Betenbaugh, M.: Overcoming apoptosis: New methods for improving protein-expression systems. TIBTECH, 16:88-95, 1998 https://doi.org/10.1016/S0167-7799(97)01159-1
  26. Mattivi, R.: Solid phase extraction of trans-resveratrol from wines for HPLC analysis. Z. Lebensm. Unters. Forsch. 196:522-525, 1993 https://doi.org/10.1007/BF01201331
  27. Moll, U.M., and Schram, L.M.: p53-an acrbat in tumorigenesis. Crit. Rev. Oral. Biol. Med., 9:23-37, 1998 https://doi.org/10.1177/10454411980090010101
  28. Nicholson, D.W., Ali, A., Thornberry, N.A., Vaillancourt, J.P., Ding, C.K., Gallant, M., Gareau, Y., Griffin, P.R., Labelle, M., Lazebnik, Y.A., Munday, N.A., Raju, S.M., Smulson, M.E., Yamin, T.T., Yu, V.L., and Miller, D.K.: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature, 376:37-43, 1995 https://doi.org/10.1038/376037a0
  29. Nicholson, W.D.,, Ali, A., Thornberry, N.A., Vaillancourt, J.P., Ding, C.K., Gallant, M., Gareau, Y., Griffin, P.R., Labelle, M., Lazebnik, Y.A., Munday, N.A., Raju, S.M., Smulsom, M.E., Yamin, T.T., Yu, V.L., and Miller, D.K.: Identificationa and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature, 326:37-43, 1995 https://doi.org/10.1038/376037a0
  30. Samuel, R.D., and John, T.I.: Programmed cell death (apoptosis) and cancer chemotherapy, Cancer Control, 3: 303-309, 1996
  31. Schlegel, J., Peters, I., Orrenius, S., Miller, D.K., Thornberry, N.A., Yamin, T.T., and Nicholson, W.D.: CPP32/Apopain is a key interleukin 1B converting enzyme-like protease involved in Fas-mediated apoptosis. J. Biol. Chem., 271:1841-1844, 1996 https://doi.org/10.1074/jbc.271.4.1841
  32. Sedlak, T.W., Olvati, Z.N., Yang, E., Ang, K., Boise, L.H., Thompson, C.B., and Korsmeyer, S.J.: Multiple bcl-2 family members demonstrate selective dimerization with bax. Proc. Natl. Acad. Sci. USA, 92:7834-7838, 1995 https://doi.org/10.1073/pnas.92.17.7834
  33. Sgambato, A., Ardito, R., Faraglia, B., Boninsegna, A., Wolf, F., and Cittadini, A.: Resveratrol, a natural phenolic compound, inhibits cell proliferation and prevents oxidative DNA damage. Mutat. Res. 496:171-180, 2001 https://doi.org/10.1016/S1383-5718(01)00232-7
  34. Shigematsu, S., Ishida, S., Hara, M., Takahashi, N., Yoshimatsu, H., Sakata, T., and Korthuis, R.J.: Resveratrol, a red wine constituent polyphenol, prevents superoxidedependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants. Free. Radic. Biol. Med. 34:810-817, 2003 https://doi.org/10.1016/S0891-5849(02)01430-2
  35. Signorelli, P., and Ghidoni, R.: Resveratrol as an anticancer nutrients: molecular basis, open questions and promises. J. Nut. Biochem. 16: 449-466, 2005 https://doi.org/10.1016/j.jnutbio.2005.01.017
  36. Stoner, G.D., and Mukhtar, H.: Polyphenols as cancer chemopreventive agents. J. Cellular. Biochem. 22:169-180, 1995 https://doi.org/10.1002/jcb.240590822
  37. Surh, Y.J., Hurh, Y.J., Kang, J.Y., Lee, E., Kong G., and Lee S.J.: Resveratrol, am amtioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL60) cells. Cancer Lett. 140:1-10, 1999 https://doi.org/10.1016/S0304-3835(99)00039-7
  38. Tewari, M., Quan, L., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D.R., Poirier, G.G., Salvesen, G.S., and Dixit, V.M.:Yama/Cpp32$\beta$, a mammalian homolog of ced-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose)polymerase. Cell, 81:801-809, 1995 https://doi.org/10.1016/0092-8674(95)90541-3
  39. Thompson, C.B.: Apoptosis in the pathogenesis and treatment of disease. Science, 267:1456-1462, 1995 https://doi.org/10.1126/science.7878464
  40. Wang, T.H., Popp, D.M., Wang, H.S., Saitoh, M., Mural, J.G., Henley, D.C., Ichijo, H., and Wimalasena., J : Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal kinase (JNK)-dependent and -independent pathway in ovarian cancer cells. J. Biol. Chem., 274:8208-8216, 1999 https://doi.org/10.1074/jbc.274.12.8208
  41. Wyllie, A.H.: Death gets a brake. Nature, 369:272-273, 1994 https://doi.org/10.1038/369272a0
  42. Yang, J., Liu, X., Bhalla, K., Kim, C.N., Ibrado, A.M., Cai, J., Peng, T.I., Jones, D.P., and Wang, X.: Prevention of apoptosis by bcl-2: Release of cytochrome c from mitochondria blocked. Science, 275:1129-1132, 1997 https://doi.org/10.1126/science.275.5303.1129